Searching across hundreds of databases
Recent research focusing on brown adipose tissue (BAT) function emphasizes its importance in systemic metabolic homeostasis. We show here that genetic and pharmacological inhibition of the mevalonate pathway leads to reduced human and mouse brown adipocyte function in vitro and impaired adipose tissue browning in vivo. A retrospective analysis of a large patient cohort suggests an inverse correlation between statin use and active BAT in humans, while we show in a prospective clinical trial that fluvastatin reduces thermogenic gene expression in human BAT. We identify geranylgeranyl pyrophosphate as the key mevalonate pathway intermediate driving adipocyte browning in vitro and in vivo, whose effects are mediated by geranylgeranyltransferases (GGTases), enzymes catalyzing geranylgeranylation of small GTP-binding proteins, thereby regulating YAP1/TAZ signaling through F-actin modulation. Conversely, adipocyte-specific ablation of GGTase I leads to impaired adipocyte browning, reduced energy expenditure, and glucose intolerance under obesogenic conditions, highlighting the importance of this pathway in modulating brown adipocyte functionality and systemic metabolism.
Pubmed ID: 30581121 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Registry and results database of federally and privately supported clinical trials conducted in United States and around world. Provides information about purpose of trial, who may participate, locations, and phone numbers for more details. This information should be used in conjunction with advice from health care professionals.Offers information for locating federally and privately supported clinical trials for wide range of diseases and conditions. Research study in human volunteers to answer specific health questions. Interventional trials determine whether experimental treatments or new ways of using known therapies are safe and effective under controlled environments. Observational trials address health issues in large groups of people or populations in natural settings. ClinicalTrials.gov contains trials sponsored by National Institutes of Health, other federal agencies, and private industry. Studies listed in database are conducted in all 50 States and in 178 countries.
View all literature mentionsThis monoclonal targets HMGCR
View all literature mentionsThis monoclonal targets CREB
View all literature mentionsThis monoclonal targets RhoA (67B9) Rabbit mAb
View all literature mentionsThis monoclonal targets gamma-Tubulin antibody produced in mouse
View all literature mentionsThis polyclonal targets IgG, H & L Chain
View all literature mentionsThis polyclonal targets Cleaved Caspase-3 (Asp175)
View all literature mentionsThis monoclonal targets
View all literature mentionsThis polyclonal targets RABGGTB
View all literature mentionsThis polyclonal targets PGGT1B antibody
View all literature mentionsThis unknown targets Goat Rabbit IgG H & L Chain Peroxidase
View all literature mentionsThis monoclonal targets HMGCS2
View all literature mentionsThis monoclonal targets Cdc42 (11A11) Rabbit mAb
View all literature mentionsThis monoclonal targets Sodium Potassium ATPase
View all literature mentionsThis monoclonal targets Hsp90aa1
View all literature mentionsThis monoclonal targets Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Asp362 of human TAZ protein
View all literature mentionsThis unknown targets UCP1
View all literature mentionsThis monoclonal targets GAPDH
View all literature mentionsThis polyclonal targets Rap1a
View all literature mentionsThis polyclonal targets Phospho-HSL (Ser660)
View all literature mentionsThis unknown targets Streptavidin-HRP
View all literature mentionsThis monoclonal targets Phospho-CREB (Ser133)
View all literature mentionsThis monoclonal targets HMGCR
View all literature mentionsThis monoclonal targets HMGCS2
View all literature mentionsThis polyclonal targets PGGT1B antibody
View all literature mentionsThis monoclonal targets Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Asp362 of human TAZ protein
View all literature mentionsThis monoclonal targets Sodium Potassium ATPase
View all literature mentionsThis unknown targets Streptavidin-HRP
View all literature mentionsThis unknown targets Goat Rabbit IgG H & L Chain Peroxidase
View all literature mentionsThis polyclonal targets IgG, H & L Chain
View all literature mentionsThis polyclonal targets Rap1a
View all literature mentionsThis monoclonal targets GAPDH
View all literature mentionsThis monoclonal targets Cdc42 (11A11) Rabbit mAb
View all literature mentionsThis monoclonal targets RhoA (67B9) Rabbit mAb
View all literature mentionsThis polyclonal targets Cleaved Caspase-3 (Asp175)
View all literature mentionsThis monoclonal targets
View all literature mentionsThis polyclonal targets Phospho-HSL (Ser660)
View all literature mentionsThis monoclonal targets gamma-Tubulin antibody produced in mouse
View all literature mentionsThis monoclonal targets Hsp90aa1
View all literature mentionsThis unknown targets UCP1
View all literature mentionsThis polyclonal targets RABGGTB
View all literature mentionsThis monoclonal targets Phospho-CREB (Ser133)
View all literature mentionsThis monoclonal targets CREB
View all literature mentionsThe SciCrunch Infrastructure was developed as a cooperative data platform to be used by diverse communities in making data more FAIR.
scicrunch.org
